S M Strakowski1, K W Sax. 1. Department of Psychiatry, University of Cincinnati College of Medicine, OH 45267-0559, USA.
Abstract
BACKGROUND: Behavioral sensitization is the process whereby intermittent stimulant exposure produces a time-dependent, enduring, and progressive behavioral response. Although animal models of sensitization are well established, the phenomenon has been relatively little studied in humans. In a previous study, we reported enhanced responses following a second as compared to a first amphetamine dose in eye-blink rate and ratings of increased motor activity/energy, increased speech, and elevated mood in normal human volunteers. This current study extends those findings in a new sample of normal volunteers. METHODS:Eleven normal human volunteers were administered three single oral doses of d-amphetamine (0.25 mg/kg) at 48-hour intervals, alternating with matched placebo in a randomized, double-blind trial. Hourly behavioral ratings included eye-blink rate, symptoms (elevated mood, increased speech, increased motor activity/energy), and subjective drug effects. RESULTS:Eye-blink rate and increased motor activity/energy ratings progressively increased following each challenge with the third amphetamine dose response significantly greater than all other conditions 4 hours postadministration. Similar, although less pronounced, responses were observed for elevated mood and subjective drug effect. CONCLUSIONS: These results provide further evidence for sensitization of some amphetamine-induced behaviors in human subjects.
RCT Entities:
BACKGROUND: Behavioral sensitization is the process whereby intermittent stimulant exposure produces a time-dependent, enduring, and progressive behavioral response. Although animal models of sensitization are well established, the phenomenon has been relatively little studied in humans. In a previous study, we reported enhanced responses following a second as compared to a first amphetamine dose in eye-blink rate and ratings of increased motor activity/energy, increased speech, and elevated mood in normal human volunteers. This current study extends those findings in a new sample of normal volunteers. METHODS: Eleven normal human volunteers were administered three single oral doses of d-amphetamine (0.25 mg/kg) at 48-hour intervals, alternating with matched placebo in a randomized, double-blind trial. Hourly behavioral ratings included eye-blink rate, symptoms (elevated mood, increased speech, increased motor activity/energy), and subjective drug effects. RESULTS:Eye-blink rate and increased motor activity/energy ratings progressively increased following each challenge with the third amphetamine dose response significantly greater than all other conditions 4 hours postadministration. Similar, although less pronounced, responses were observed for elevated mood and subjective drug effect. CONCLUSIONS: These results provide further evidence for sensitization of some amphetamine-induced behaviors in human subjects.
Authors: Brook L Henry; Arpi Minassian; Jared W Young; Martin P Paulus; Mark A Geyer; William Perry Journal: Neurosci Biobehav Rev Date: 2010-04-14 Impact factor: 8.989
Authors: Camila S Model; Lara M Gomes; Giselli Scaini; Gabriela K Ferreira; Cinara L Gonçalves; Gislaine T Rezin; Amanda V Steckert; Samira S Valvassori; Roger B Varela; João Quevedo; Emilio L Streck Journal: Metab Brain Dis Date: 2014-01-03 Impact factor: 3.584
Authors: Ellie-Anna Minogianis; Waqqas M Shams; Omar S Mabrouk; Jenny-Marie T Wong; Wayne G Brake; Robert T Kennedy; Patrick du Souich; Anne-Noël Samaha Journal: Eur J Neurosci Date: 2018-07-24 Impact factor: 3.386
Authors: Ana O Fagundes; Giselli Scaini; Patricia M Santos; Monique U Sachet; Nayara M Bernhardt; Gislaine T Rezin; Samira S Valvassori; Patrícia F Schuck; João Quevedo; Emilio L Streck Journal: Neurochem Res Date: 2009-09-24 Impact factor: 3.996
Authors: Jennifer L Temple; Alison M Bulkley; Rebecca L Badawy; Nicole Krause; Sarah McCann; Leonard H Epstein Journal: Am J Clin Nutr Date: 2009-05-20 Impact factor: 7.045